Treatment of acute non lymphocytic leukemia. Results of a prospective trial of daunorubicin, arabinosylcytosine and 6-thioguanine (DAT) versus DAT plus vindesine and etoposide.
Bandini G, Baccarani M, Cavazzini G, +7 more·Haematologica
Abstract not available